Bill > S0866

This bill amends Florida Statute 893.0551, which deals with the confidentiality of information within the state's prescription drug monitoring program, to clarify and strengthen the rules around when certain confidential information can be shared. Specifically, it refines the conditions under which the Attorney General, health care regulatory boards (which are state boards that license and oversee healthcare professionals), and law enforcement agencies can disclose this protected information. The key change is that these entities can only share such information if it is relevant to an active investigation that prompted their request, and they must take steps to ensure the continued confidentiality of the information, such as redacting irrelevant details. The bill also adds provisions for impaired practitioner consultants to access this information for evaluation purposes and clarifies how health care practitioners can use and share patient information they receive. Furthermore, it reinforces that any agency or person obtaining this confidential information must maintain its protected status and can only disclose it if authorized by the law. Finally, the bill removes a sunset provision, meaning this exemption from public records laws will no longer automatically expire.